EORTC

Skip to content Back to Clinical Trials Database Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma…

Read the full article here

Source: EORTC

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: BrainCancer, CancerResearch, ClinicalTrial, medulloblastoma

Tweets with this article

EORTC

EORTC-1634-BTG PersoMed-I academic phase II #ClinicalTrial is open for patient recruitment. First worldwide randomized trial in post-pubertal and adults newly diagnosed with #medulloblastoma. More: https://t.co/GWaBMhq2Sa @GatewayforCR @gminniti2012 #CancerResearch #BrainCancer https://t.co/HDUteGBoNj

Young & Early Career Investigator – EORTC

EORTC is dedicated to fostering the development of young doctors working in the EORTC network in clinical and translational cancer research. We want to help

EORTC April 18, 2024

We Are Hiring A Clinical Data Manager

At EORTC, we are looking for a Clinical Data Manager to join our HQ team in Brussels.

EORTC April 10, 2024

Cancer Medicines Forum workshop: April 2024 | European Medicines Agency

European Medicines Agency, Amsterdam, the Netherlands The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are co-chairing the…

EORTC April 5, 2024

Cancer Medicines Forum Workshop – EORTC

The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate

EORTC March 28, 2024

Cancer Medicines Forum Workshop – EORTC

The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate

EORTC March 25, 2024